Apnea as a manifestation of systemic mast cell activation in an infant with systemic mastocytosis.

被引：0
|
作者：
Arnaout, RK [1 ]
Irani, A [1 ]
Schwartz, LB [1 ]
机构：
[1] VIRGINIA COMMONWEALTH UNIV,RICHMOND,CA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1997年 / 99卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2001 / 2001
页数：1
相关论文
共 50 条
  • [21] SYSTEMIC MASTOCYTOSIS. RETROSPECTIVE REVIEW IN OUR CENTRE
    Eduardo Jose, Salido Fierrez
    Perianes Valentin, Cabanas
    Raul, Perez-Lopez
    Faustino, Garcia-Candel
    Piqueras Mercedes, Berenguer
    Juan Jose, Cerezo Manchado
    Ana Maria, Garcia-Hernandez
    Amor Antonia, Melero
    Arnao Maria, Moya
    Marin Amelia, Martinez
    Poveda Elena, Fernandez
    Almenzar Begona, Navarro
    Laura, Sanchez-Munoz
    Ivan, Alvarez-Twose
    Jose Maria, Moraleda Jimenez
    HAEMATOLOGICA, 2016, 101 : 190 - 190
  • [22] Histidine decarboxylase (HDC) as novel marker of immature neoplastic mast cells in systemic mastocytosis.
    Krauth, MT
    Agis, H
    Aichberger, KJ
    Simonitsch, I
    Muellauer, L
    Mayerhofer, M
    Horny, HP
    Valent, P
    BLOOD, 2004, 104 (11) : 272B - 272B
  • [23] Systemic mastocytosis. A GIMEMA multicenter survey.
    Pagano, Livio
    Valentini, Caterina Giovanna
    Musto, Pellegrino
    Caira, Morena
    Rondoni, Michela
    Van Lint, Maria Teresa
    Candoni, Anna
    Martinelli, Giovanni
    Gatto, Simona
    Cattaneo, Chiara
    Marbello, Laura
    Caramatti, Cecilia
    Castagnola, Carlo
    Pogliani, Enrico Maria
    Mitra, Maria Enza
    Giona, Fiorina
    Fanci, Rossella
    Fianchi, Luana
    Sanpaolo, Grazia
    Pulsoni, Alessandro
    Leone, Giuseppe
    BLOOD, 2006, 108 (11) : 304B - 304B
  • [24] The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
    Butterfield, Joseph
    Weiler, Catherine R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2533 - 2541
  • [25] Dasatinib (Sprycel™) therapy for patients with systemic mastocytosis.
    Verstovsek, Srdan
    Kantarjian, Hagop
    Cortes, Jorge
    Ravandi-Kashani, Farhard
    Borthakur, Gautam
    Nicaise, Claude
    Sams, Inga
    Giles, Francis
    Tefferi, Ayalew
    BLOOD, 2006, 108 (11) : 1036A - 1036A
  • [26] Smoldering systemic mastocytosis. Successful therapy with cladribine
    Schleyer, V
    Meyer, S
    Landthaler, M
    Szeimies, RM
    HAUTARZT, 2004, 55 (07): : 658 - 662
  • [27] DNA methylation profile in patients with indolent systemic mastocytosis.
    Gorska, A.
    Jablonska, E.
    Reszka, E.
    Niedoszytko, M.
    Lange, M.
    Gruchala-Niedoszytko, M.
    Jarczak, J.
    Strapagiel, D.
    Gorska-Ponikowska, M.
    Bastian, P.
    Pelikant-Malecka, I
    Nedoszytko, B.
    ALLERGY, 2021, 76 : 389 - 389
  • [28] Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome
    Degboe, Y.
    Eischen, M.
    Apoil, P. A.
    Mailhol, C.
    Dubreuil, P.
    Hermine, O.
    Paul, C.
    Livideanu, C. Bulai
    Laroche, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1235 - 1241
  • [29] Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome
    Y. Degboé
    M. Eischen
    PA. Apoil
    C. Mailhol
    P. Dubreuil
    O. Hermine
    C. Paul
    C. Bulai Livideanu
    M. Laroche
    Osteoporosis International, 2019, 30 : 1235 - 1241
  • [30] Digestive Lesions in Systemic Mastocytosis. A Study of 23 Patients
    Canioni, D.
    Sokol, H.
    Hoyeau, N.
    Barete, S.
    Soppelsa, F.
    Dubreuil, P.
    Lortholary, O.
    Hermine, O.
    MODERN PATHOLOGY, 2010, 23 : 139A - 139A
12345